Zobrazeno 1 - 10
of 17
pro vyhledávání: '"J A Lockton"'
Autor:
J Langton-Lockton, TR Phillips, Basil Donovan, Sarah J Martin, Alison Ward, Chris Bourne, Jason J. Ong, Darren Russell, Lewis Marshall, Christopher K Fairley, Manoji Gunathilake, Anna McNulty, Epf Chow, David J Templeton, Louise S Owen
Publikováno v:
Poster presentations.
Background We aimed to examine the changes public sexual health services across Australia made during the national lockdown (March-May 2020) due to the COVID-19 pandemic. Methods From July-August 2020, we emailed a link to an online survey to 21 sexu
Autor:
F. Francis, David M. Whiley, Ella Trembizki, Emma L. Sweeney, Catriona S. Bradshaw, J. Langton-Lockton, A. Menon, Cheryl Bletchly, Graeme R. Nimmo
Publikováno v:
Journal of Clinical Microbiology. 57
Mycoplasma genitalium is frequently associated with urogenital and rectal infections, with the number of cases of macrolide-resistant and quinolone-resistant M. genitalium infection continuing to increase. In this study, we examined the levels of res
Autor:
E L, Sweeney, E, Trembizki, C, Bletchly, C S, Bradshaw, A, Menon, F, Francis, J, Langton-Lockton, G R, Nimmo, D M, Whiley
Publikováno v:
Journal of clinical microbiology. 57(3)
Mycoplasma genitalium is frequently associated with urogenital and rectal infections, with the number of cases of macrolide-resistant and quinolone-resistant M. genitalium infection continuing to increase. In this study, we examined the levels of res
Autor:
E Leverton, Simon M. Poucher, Peter G. Morris, J A Lockton, E. Y. H. Khoo, Jan W. Eriksson, Peter Mansell, Ian A. Macdonald, Mary C. Stephenson, Lars Johansson
Publikováno v:
NMR in Biomedicine. 26:1518-1526
The measurement of tissue lipid and glycogen contents and the establishment of normal levels of variability are important when assessing changes caused by pathology or treatment. We measured hepatic and skeletal muscle lipid and glycogen levels using
Publikováno v:
British Journal of Clinical Pharmacology. 57:162-169
Aims The primary objectives of the present study were to establish whether there was a pharmacokinetic or pharmacodynamic interaction between the probe drugs caffeine (CYP1A2), tolbutamide (CYP2C9), debrisoquine (CYP2D6), chlorzoxazone (CYP2E1) and m
Publikováno v:
British Journal of Clinical Pharmacology. 51:249-255
Aims To determine whether there is a pharmacokinetic interaction between the antiepileptic drugs remacemide and phenobarbitone. Methods In a group of 12 healthy adult male volunteers, the single dose and steady-state kinetics of remacemide were each
Autor:
M C, Stephenson, E, Leverton, E Y H, Khoo, S M, Poucher, L, Johansson, J A, Lockton, J W, Eriksson, P, Mansell, P G, Morris, I A, MacDonald
Publikováno v:
NMR in biomedicine. 26(11)
The measurement of tissue lipid and glycogen contents and the establishment of normal levels of variability are important when assessing changes caused by pathology or treatment. We measured hepatic and skeletal muscle lipid and glycogen levels using
Publikováno v:
Journal of Epidemiology & Community Health. 47:89-95
OBJECTIVES--To assess and compare the prevalence of established risk markers for ischaemic heart disease in a sample of Asian and non-Asian men and to relate these observations to preventive strategies. SETTING--Two factories in the textile industry
Publikováno v:
International Journal Of Pharmaceutical Medicine. 15:227-229
The objective of the study was to determine practical issues associated with rapid intravenous infusion delivery of volumes up to 100 ml. The study was of an open, randomized, three-way crossover design, and was conducted in 20 healthy volunteers. Ea
Autor:
J. Andrew Lockton, Richard Eastell, Richard D. Finkelman, Glen Clack, Rosemary A. Hannon, Martin Rimmer, Alan Swaisland
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 25(3)
Src is a nonreceptor tyrosine kinase thought to be essential for osteoclast function and bone resorption. We investigated the effect of the orally available Src inhibitor saracatinib (AZD0530) on bone turnover in healthy men. The study was part of a